Emergent Biosolutions (EBS)
(Real Time Quote from BATS)
$8.96 USD
+0.05 (0.56%)
Updated Aug 29, 2024 03:55 PM ET
After-Market: $8.91 -0.05 (-0.56%) 4:14 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Price, Consensus and EPS Surprise
EBS 8.96 +0.05(0.56%)
Will EBS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EBS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EBS
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
EBS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Repligen (RGEN) Q2 Earnings Meet Estimates
Myriad (MYGN) Down 5.2% Since Last Earnings Report: Can It Rebound?
Axsome (AXSM) Down 6.1% Since Last Earnings Report: Can It Rebound?
Other News for EBS
Spain and Germany to donate mpox vaccine doses to Africa
Tonix stock jumps on collaboration for mpox vaccine candidate
Trinity stock soars post-market on raised guidance, increased capacity
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped'
WHO says $135M needed to counter mpox outbreak